ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,298 | -13.8% | 379,800 | +10.5% | 0.00% | 0.0% |
| Q2 2023 | $2,667 | +36.0% | 343,700 | -0.1% | 0.00% | +33.3% |
| Q1 2023 | $1,961 | +5.1% | 344,100 | +8.6% | 0.00% | 0.0% |
| Q4 2022 | $1,866 | -99.9% | 316,800 | -21.1% | 0.00% | +50.0% |
| Q3 2022 | $1,284,000 | -36.0% | 401,400 | -10.4% | 0.00% | 0.0% |
| Q2 2022 | $2,006,000 | +71.5% | 447,869 | +104.4% | 0.00% | +100.0% |
| Q1 2022 | $1,170,000 | +202.3% | 219,100 | +733.1% | 0.00% | – |
| Q4 2021 | $387,000 | – | 26,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |